the right deal would no doubt be wonderful, but I think an announcement of an IBD trial in pill form targeted at specific regions of regions of the gut and a pill delivery method for a K trial would be very positive steps that would move the needle.
Go look at the previous 5 years of trials and their data. I think BOM -----Will be the # 1 preventative drug to market. And the data can actually be much worse than our interim and we still will be the first to market PREVENTATIVE IMO.
A company just paid 108 million and gave up double digit royalties for an OM drug that only prevents SOM 55% of the time. That deal was done in September.
News 
Market Data 
Discover 
